The Europe Disposable Syringes Market would witness market growth of 5.9% CAGR during the forecast period (2023-2030).
Disposable syringes are quickly replacing traditional glass syringes because they are inexpensive, ready to use, and readily available in a sterilized condition. The usage of these syringes has increased dramatically as the scourge of AIDS has virtually abolished the practice of using previously used needles. The majority of disposable syringes are injection-molded polypropylene. Syringes comprise two or three parts and come in sizes of 1 ml, 2 ml, 5 ml, and 10 ml. The quantity and size of injection molding machines required are determined by the syringe design, the number of mold cavities, and the annual output.
The manufacturers are investing in various nations by introducing new products. One of the main drivers of the target market's growth is the existence of significant industry players, modern healthcare infrastructure, and government initiatives. Organizations are improving the quality and services related to disposable syringes while lowering the cost of their products. These operational strategies help organizations save money by lowering third-party expenses. These characteristics are expected to create lucrative potential for market expansion.
In Europe, diabetes is growing more prevalent among people of all ages due to rising rates of overweight and obesity, a bad diet, and insufficient exercise. Sixty million people in the European region have diabetes, representing 10.3% of men and 9.6% of women who are 25 years of age or older. Furthermore, diabetes has been detected in 15.3% of Germans, according to the International Diabetes Federation (IDF). The requirement for preventive treatment comes from the rising prevalence of diabetes. Thus, the demand across the region is predicted to grow as a result.
The Germany market dominated the Europe Disposable Syringes Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,416.6 Million by 2030. The UK market is exhibiting a CAGR of 5% during (2023 - 2030). Additionally, The France market would display a CAGR of 6.7% during (2023 - 2030).
Based on Application, the market is segmented into Therapeutic Injections, and Immunization Injections. Based on Product, the market is segmented into Safety Syringes (Retractable, and Non-retractable), and Conventional Syringes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Disposable Syringes Market is Projected to reach USD 22.5 Billion by 2030, at a CAGR of 6.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Fresenius SE & Co. KGaA, Terumo Corporation, Novo Nordisk A/S, Baxter International, Inc., B. Braun Melsungen AG, Flextronics International, Ltd., Nipro Corporation, and UltiMed, Inc.
By Application
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
